Clinical Investigator
Stephen Shrewsbury, MD
Impel Pharmaceuticals
Total Trials
1
As PI
0
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 21
Trial Status
Terminated1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
Agitation in Adolescents and Young Adults With ASD
StudychairStart date: 2022-06-23
Research Network
Collaboration Network
19 collaborators·19 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Impel Pharmaceuticals
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Matthew Siegel, MD
Maine Behavioral Healthcare
1 trials
Shared therapeutic areas:
Agitation in Adolescents and Young Adults With ASD
Worked with same sponsors:
Impel Pharmaceuticals
Collaborated on 1 trial
Similarity Score14%
Craig Erickson, MD
Children's Hospital Medical Center, Cincinnati
5 trials
Shared therapeutic areas:
Agitation in Adolescents and Young Adults With ASD
Worked with same sponsors:
Impel Pharmaceuticals
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
Agitation in Adolescents and Young Adults With ASD
All 1 trials loaded